14.02.2018 • News

Restricted Chemicals Found in Consumer Products

An inspection by the ECHA has found hundreds of consumer products containing...
An inspection by the ECHA has found hundreds of consumer products containing chemicals that are restricted under REACH legislation

An inspection by the European Chemicals Agency (ECHA) has found hundreds of consumer products containing chemicals that are restricted under REACH legislation. The investigation by ECHA's enforcement forum in 2016 discovered phthalates, cadmium and asbestos, all of which are highly restricted under REACH’s Annex XIV rule and prohibited without specific authorization.

The agency said that out of 5,625 product checks, 18% did not comply with the restrictions. The most frequent breaches were phthalates in toys, with 20% of those inspected containing bis(2-ethylhexyl) (DEHP), dibutyl phthalate (DBP) or benzyl butyl phthalate (BBP) at levels above those permitted.

In addition, cadmium was found in 14% of brazing fillers, and asbestos fibers were discovered in 14% of the products tested, including catalytic heaters, thermos flasks and brake pads.  However, the agency noted that the products containing asbestos were mostly second-hand and likely produced before the restrictions came into force.

Inspectors also found high concentrations of chromium VI in leather articles (13%), cadmium in jewelry (12%) and polycyclic aromatic hydrocarbons (8%) in (undisclosed) products.  In addition, there was an 88.5 % non-compliance rate in the 392 product checks for measuring devices, most of which contained mercury above the legal limit.

ECHA said the report highlighted companies’ responsibility to get information on the chemical composition of their products from suppliers. The authority said it will continue to enforce REACH restrictions by analyzing further products on the market.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

29 April 2026 | This webinar explores how chemical industry organizations can design a digital‑ and AI‑ready operating model focused on clarity, usability, and measurable value.

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

most read